The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for V Varalakshmi & Padmanaban Krishnamorrthy
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.2 pts less than Nifty Microcap 250 and 1.8 pts less than its Pharmaceuticals & Biotechnology peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Ms. V Varalakshmi, along with Mr. Padmanaban Krishnamoorthy (Person Acting in Concert), has filed a disclosure under SEBI's Takeover Regulations. Mr. Padmanaban Krishnamoorthy acquired 9,00,200 equity shares (6.92% of paid-up capital) through shares tendered under an Open Offer, with consideration paid on 16 December 2025. Ms. V Varalakshmi continues to hold 72,69,500 shares (55.92%), and together their combined holding stands at 81,69,700 shares (62.84%) of the company. The acquirers have clarified they do not belong to the promoter or promoter group of the company.
This is a regulatory disclosure for shares received via the Open Offer mechanism and does not represent a fresh promoter-level change. Shareholders should note that the combined holding of the acquirer and PAC now stands at 62.84%, reflecting consolidation through the open offer route rather than open-market purchases.